Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Stanford Amyloid Center is at the forefront of amyloidosis treatment and research. We offer clinical trials and are dedicated to learning more about the disease and advancing treatment options. Our center provides an integrated, multidisciplinary approach to the care of our patients.
Coordinated care and treatment of amyloidosis
Because amyloidosis affects multiple organs in the body, it is important to have a comprehensive and coordinated treatment plan that address all aspects of the disease.
At our center, we bring together experts across 10 specialties who develop an individualized treatment plan for you.
Our team includes Stanford specialists in the following areas:
Do you know if you're at risk for heart disease? How healthy is your heart? In recognition of American Heart Month this February, stay heart healthy and celebrate your heart with us.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.